Skip to main content
AN2 Therapeutics, Inc. logo

AN2 Therapeutics, Inc. — Investor Relations & Filings

Ticker · ANTX ISIN · US0373261058 US Manufacturing
Open in API
Filings indexed 339 across all filing types
Latest filing 2023-11-14 Regulatory Filings
Country US United States of America
Listing US ANTX

About AN2 Therapeutics, Inc.

https://www.an2therapeutics.com/

AN2 Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing treatments for rare, chronic, and serious infectious diseases with high unmet medical needs. The company utilizes its proprietary boron chemistry platform to create novel small molecule therapeutics. Its development pipeline includes boron-based compounds, such as its lead candidate epetraborole, which are being investigated as potential first-in-class or best-in-class therapies. The company's mission is to deliver high-impact drugs to improve global health outcomes, with potential applications extending to oncology.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2023
Regulatory Filings
2023-11-14 English
10-Q
Interim / Quarterly Report 9M 2023
2023-11-09 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 9, 2023, reporting the issuance of a press release announcing financial results for the third quarter ended September 30, 2023. The text explicitly states that the press release is attached as Exhibit 99.1 and incorporated by reference, and that the information is "furnished" and not "filed." The document itself does not contain the financial results or detailed financial statements but rather announces their release. The length is 3499 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, such a document that announces or furnishes a report but does not contain the substantive financial data should be classified as a Regulatory Filing (RNS), as it is a general regulatory announcement and does not fit other specific categories like Earnings Release or Interim Report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-11-09 English
4
Director's Dealing
2023-10-04 English
4
Director's Dealing
2023-10-04 English
Regulatory Filings 2023
Regulatory Filings
2023-10-02 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.